FDA Drug Application (022108) for APLENZIN by VALEANT PHARMS NORTH

Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Application Number022108
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage174MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPLENZIN
Active IngredientBUPROPION HYDROBROMIDE

Active IngredientCount
List of drugs with Active Ingredient BUPROPION HYDROBROMIDE2


Back to FDA Applications sponsored by VALEANT PHARMS NORTH